Ebn Sina Medical, a subsidiary of Aamal Company, and Danish healthcare major Novo Nordisk have launched the weight loss ...

Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

The decline was sharper after 2016, likely due to advancements in treatment options, greater uptake of precision medicine, ...

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

The WHO's conditional recommendation will be officially released in August, as part of new guidelines on treating obesity. It ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance ...

A major clinical trial reveals Wegovy a popular weight loss drug also treats serious liver disease MASH—reducing liver inflammation and scarring in most patients ...

A recent study reveals that semaglutide, a diabetes medication known for its weight-loss effects, shows promise in treating ...

Eli Lilly & Co.’s shares saw the biggest one-day drop since 2008 after CVS Health Corp. announced a plan to drop its ...